125 related articles for article (PubMed ID: 26768588)
1. Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy.
Yang SF; Hou MF; Chen FM; Ou-Yang F; Wu YC; Chai CY; Yeh YT
BMC Cancer; 2016 Jan; 16():20. PubMed ID: 26768588
[TBL] [Abstract][Full Text] [Related]
2. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
3. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
4. ObRb downregulation increases breast cancer cell sensitivity to tamoxifen.
Qian Y; Shi D; Qiu J; Zhu F; Qian J; He S; Shu Y; Yin Y; Chen X
Tumour Biol; 2015 Sep; 36(9):6813-21. PubMed ID: 25846733
[TBL] [Abstract][Full Text] [Related]
5. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
6. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
Ishii Y; Waxman S; Germain D
Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
[TBL] [Abstract][Full Text] [Related]
8. A positive feedback loop between miR-181b and STAT3 that affects Warburg effect in colon cancer via regulating PIAS3 expression.
Pan X; Feng J; Zhu Z; Yao L; Ma S; Hao B; Zhang G
J Cell Mol Med; 2018 Oct; 22(10):5040-5049. PubMed ID: 30054984
[TBL] [Abstract][Full Text] [Related]
9. Suppression of STAT3 NH
Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
11. The role of PIAS3, p-STAT3 and ALR in colorectal cancer: new translational molecular features for an old disease.
Polimeno L; Francavilla A; Piscitelli D; Fiore MG; Polimeno R; Topi S; Haxhirexha K; Ballini A; Daniele A; Santacroce L
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10496-10511. PubMed ID: 33155205
[TBL] [Abstract][Full Text] [Related]
12. miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration.
Wang Z; Han J; Cui Y; Zhou X; Fan K
Biochem Biophys Res Commun; 2013 Sep; 439(3):384-9. PubMed ID: 23998932
[TBL] [Abstract][Full Text] [Related]
13. PIAS3 expression in human gastric carcinoma and its adjacent non-tumor tissues.
Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
Clin Res Hepatol Gastroenterol; 2011 May; 35(5):393-8. PubMed ID: 21334998
[TBL] [Abstract][Full Text] [Related]
14. 3-Formylchromone inhibits proliferation and induces apoptosis of multiple myeloma cells by abrogating STAT3 signaling through the induction of PIAS3.
Ko JH; Ho Baek S; Nam D; Chung WS; Lee SG; Lee J; Mo Yang W; Um JY; Seok Ahn K
Immunopharmacol Immunotoxicol; 2016 Oct; 38(5):334-43. PubMed ID: 27324722
[TBL] [Abstract][Full Text] [Related]
15. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
16. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
[TBL] [Abstract][Full Text] [Related]
17. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.
Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A
Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337
[TBL] [Abstract][Full Text] [Related]
18. YB1 protects cardiac myocytes against H2O2‑induced injury via suppression of PIAS3 mRNA and phosphorylation of STAT3.
Wang S; He F; Li Z; Hu Y; Huangfu N; Chen X
Mol Med Rep; 2019 Jun; 19(6):4579-4588. PubMed ID: 30942400
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma.
He T; McColl K; Sakre N; Chen Y; Wildey G; Dowlati A
Mol Oncol; 2018 Dec; 12(12):2124-2135. PubMed ID: 30259640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
